|

MIB-626 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Brigham and Women's Hospital1

Indications

  • Alzheimer's Disease1
  • Alzheimer's Disease (Incl Subtypes)1
  • Dementia1

Boston, Massachusetts1 trial

Sirtuin-NAD Activator in Alzheimer's Disease

Brigham and Women's Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.